Schedule 13G ownership disclosure

IMMUNOGEN INC

Security class unavailable · CUSIP: 45253H101

Event date: 2016-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,138,629
Percent of class
11.6400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-126546
Form type
SC 13G/A
Filer
ImmunoGen, Inc.
CIK
CIK 855654
Filed
Jun 10, 2016
Reporting period
May 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub